Published: Sat, February 04, 2017
Economy | By Melissa Porter

Large Cap Medical Appliances & Equipment: Boston Scientific Corporation (NYSE:BSX)

Large Cap Medical Appliances & Equipment: Boston Scientific Corporation (NYSE:BSX)

It is predicted to add 4% on day 1 and jump 4% on day 7 after the company reports upcoming earnings.

Revenue for the fourth quarter rose 11% to $ 2.19 billion from $ 1.98 billion in the same quarter past year.

Boston Scientific Corporation develops manufactures and markets medical devices.

Boston Scientific (NYSE:BSX) put black ink in the ledger for the 4th quarter and 2016 today, beating the sales and earnings consensus for both periods in the process.

The firm has a 50 day moving average of $22.81 and a 200-day moving average of $22.88. Boston Scientific Corporation has 1 year price target of $27.69. Finally, BTIG Research reiterated a "neutral" rating on shares of Boston Scientific Corporation in a research report on Sunday, January 8th. The Market Capitalization of the company stands at 34.18 Billion. The current consensus estimate compares to last year's same quarter result of $0.26 a share and an increase of 11.54%. According to their observations and findings, the stock could provide a high EPS of $0.32/share and a Low EPS of $0.29/share. On average, equities analysts forecast that Boston Scientific Corporation will post $1.10 earnings per share for the current year. There are 5 equity research firms advocating a Hold and 0 consider it Sell. Needham & Company LLC increased their target price on Boston Scientific Corporation to $29.00 and gave the company a "buy" rating in a research report on Thursday. TheStreet raised Boston Scientific Corporation from a c+ rating to a b rating in a report on Tuesday, January 17th.

The number of Boston Scientific Corporation shares in issue is 1,361,677,000 which have a current share price of 25.01 bringing Boston Scientific Corporation's market capitalisation to 34.06B United States dollars. Its SVP and President, Endoscopy Pierce David A sold 10,232 company shares for $227000.56, in a transaction on 2017-01-09. And a quick view of analyst notes show that 12 are rating the stock a buy while 9 rate BSX a strong buy. The stock now has a consensus rating of "Buy" and a consensus price target of $25.79. The stock was sold at an average price of $20.48, for a total value of $547,348.48. The number of shares now owned by investors are 543.92 mln. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Meanwhile, EVP, GC & Chief Admin Officer Pratt Timothy A. sold 6,195 shares worth $137000.78, through a transaction dated 2017-01-09. The 52-week range of the share price is from $33.60 - $53.21. Following the completion of the sale, the executive vice president now owns 231,273 shares of the company's stock, valued at $5,143,511.52. The disclosure for this sale can be found here.

Twitter, Inc. (NYSE:TWTR) ended its day at $17.78 with the rising stream of 3.13% and its total traded volume was 19.33 million shares more than the average volume.

Boston Scientific Corporation Gross Margin percentage stands at 71.3% while its Operating Margin for trailing twelve month is 0.4 percent and Profit margin (ttm) is 1 Percent.

Like this: